Global Health News and Research

RSS

JAK inhibitors or type I interferon shown to reduce mortality in COVID-19

Now, a new study by researchers at Yale University and published on the preprint server medRxiv in August 2020 reports that the use of two drug categories, namely, JAK inhibitors and Type I interferons (IFNs), is associated with a dramatic improvement in mortality in COVID-19.

13 Aug 2020

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.

13 Aug 2020

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have launched the COVID-19 Unit for Research at Elmhurst (CURE-19).

12 Aug 2020

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

11 Aug 2020

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19)

Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.

9 Aug 2020

New WHO Science Council to support latest advances in technology

As a science-based institution, WHO is always striving to be at the forefront of scientific progress and its potential to improve health for all.

6 Aug 2020

A SARS-CoV-2 assay using plant proteins

Researchers in South Africa have developed a serological assay that readily detects antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using recombinant viral proteins produced in plants.

5 Aug 2020

New iron intervention study fights anemia with advanced computer simulation

A new iron intervention study has determined which of the world's low-and-middle income countries would benefit from using iron-containing micronutrient powders to tackle childhood anaemia.

4 Aug 2020

A quarter of arthritis cases in the U.S. are attributable to excess weight, shows study

A new Boston University School of Public Health study shows that weight loss between early adulthood and midlife lowers arthritis risk, and found no evidence of any persistent risk of arthritis for people who were heavier earlier in life and then lost weight.

4 Aug 2020

There could be 7 million unplanned pregnancies because of COVID-19

The coronavirus pandemic has rippled across the globe, infecting nearly 18 million individuals worldwide to date. Though the coronavirus disease (COVID-19) affects people from all walks of life, women and girls may experience devastating effects of the outbreak.

2 Aug 2020

UVA now supports engineering-to-medicine faculty fellowships

The University of Virginia's Center for Engineering in Medicine now supports faculty fellowships that embed engineering faculty members within the UVA School of Medicine.

31 Jul 2020

War of sugars - estrogen provides protection in COVID-19

Now a new study published on the preprint server bioRxiv in July 2020 reports that sex hormones could affect the function of the fusion protein that is dependent upon the human ACE2 receptor, thus preventing the entry of the virus into the host cell.

31 Jul 2020

Oxford/Berlin partnership moves forward with the establishment of Centre for Advanced Studies

The Berlin University Alliance and the University of Oxford are taking forward their research partnership with the establishment of a Centre for Advanced Studies.

29 Jul 2020

New edition of trilateral study on access to medical technologies and innovation launched

On 29 July, the Directors-General of the World Health Organization, the World Intellectual Property Organization and the WTO presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation.

29 Jul 2020

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Low- and middle-income countries could see HIV, tuberculosis (TB), and malaria deaths increase by up to 36 per cent over the next five years because of COVID-19-induced health services disruptions, a study projects.

29 Jul 2020

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Researchers from the Los Alamos National Laboratory and Duke Human Vaccine Institute & Department of Surgery demonstrated that globally prevalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the amino acid substitution D614G in the spike protein is much more infective due to profitable binding encounters with the host receptors.

28 Jul 2020

Researchers analyze global trends of antibiotic consumption in each WHO AWaRe category

Antibiotic consumption per capita increased nearly 40 percent worldwide between 2000 and 2015, primarily driven by increases in low- and middle-income countries (LMICs) where lack of access to antibiotics exists alongside overuse.

28 Jul 2020

UT Southwestern Medical Center ranks among the top 50 hospitals

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation's fourth-largest metro area – and ranks among the top 50 hospitals nationally in 10 specialties ranging from brain to heart care, according to U.S. News & World Report's annual Best Hospitals report released today. Six of the specialties rank in the top 25.

28 Jul 2020

Global Health News and Research

JAK inhibitors or type I interferon shown to reduce mortality in COVID-19

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Finland joins international organization dedicated to COVID-19 vaccines

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19)

New WHO Science Council to support latest advances in technology

A SARS-CoV-2 assay using plant proteins

New iron intervention study fights anemia with advanced computer simulation

A quarter of arthritis cases in the U.S. are attributable to excess weight, shows study

There could be 7 million unplanned pregnancies because of COVID-19

UVA now supports engineering-to-medicine faculty fellowships

War of sugars - estrogen provides protection in COVID-19

Oxford/Berlin partnership moves forward with the establishment of Centre for Advanced Studies

New edition of trilateral study on access to medical technologies and innovation launched

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Researchers analyze global trends of antibiotic consumption in each WHO AWaRe category

UT Southwestern Medical Center ranks among the top 50 hospitals

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News